Clinical Advances in Urinary Surgery

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nephrology & Urology".

Deadline for manuscript submissions: 30 June 2025 | Viewed by 2502

Special Issue Editors


E-Mail Website
Guest Editor
The Department of Urology, Sheba Medical Center, Ramat Gan 5262000, Israel
Interests: surgery; endourology; laparoscopic urology; urologic oncology; urolithiasis

E-Mail Website
Guest Editor
1. The Department of Urology, Sheba Medical Center, Ramat Gan 5262000, Israel
2. School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel
Interests: surgery; endourology; laparoscopic urology; urologic oncology; urolithiasis

Special Issue Information

Dear Colleagues,

Urinary tract pathologies comprise oncologic conditions, functional disorders, urolithiasis, infectious diseases, and others. Over the years, significant progress has been made in the diagnosis and evaluation of urologic conditions, advanced imaging techniques, and various new and improved treatment modalities. Robotic surgery represents the latest development in surgical technology and has become an established tool in the treatment of different urinary conditions, malignant and benign. Endoscopic and other minimally invasive procedures are constantly being developed and provide a wide range of surgical solutions.

We invite original research articles, comprehensive reviews, and clinical studies that contribute to the existing knowledge of urinary surgery. Submissions should focus on clinical insights, recent progress, and the application of new technologies in the field.

Dr. Nir Kleinmann
Dr. Asaf Shvero
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • endourology
  • laparoscopic urology
  • urologic oncology
  • urolithiasis
  • robot-assisted surgery
  • endoscopic surgery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 911 KiB  
Article
Robot-Assisted Pyelolithotomy in Pelvic Kidney
by Husny Mahmud, Asaf Shvero, Nir Kleinmann, Zohar A. Dotan and Dorit E. Zilberman
J. Clin. Med. 2024, 13(24), 7727; https://doi.org/10.3390/jcm13247727 - 18 Dec 2024
Viewed by 717
Abstract
Background/Objectives: Pelvic kidney is a congenital anomaly characterized by the kidney’s failure to ascend to its normal anatomical location during early embryonic development. This anomaly complicates traditional surgical approaches for renal calculi due to the kidney’s atypical positioning and associated anatomical challenges. We [...] Read more.
Background/Objectives: Pelvic kidney is a congenital anomaly characterized by the kidney’s failure to ascend to its normal anatomical location during early embryonic development. This anomaly complicates traditional surgical approaches for renal calculi due to the kidney’s atypical positioning and associated anatomical challenges. We sought to summarize our experience with robotic-assisted pyelolithotomy (RPPK) for pelvic kidney stones. Methods: A retrospective review of patients who underwent RPPK was conducted between 2014 and 2023. Demographic data on stone characteristics, operative details, and postoperative outcomes were analyzed. Results: Four patients (three male; mean age—51.2 years with a range of 45–54; mean BMI—26.6 with a range of 22.3–32.2) underwent RPPK. All had a right-sided pelvic kidney; two had prior failed ureteroscopy. The mean stone diameter was 27.7 mm (range: 17–35); the mean density was 1207.5 HU (range: 905–1500). The mean operative time was 265 min (range: 200–323); the time from incision to closure was 142.2 min (range: 95–225). No ureteral stents or drains were used. Blood loss was negligible. The mean hospital stay was 2.2 days. No immediate complications were recorded. The mean follow-up was 11.75 months (range: 3–30). Conclusions: RPPK is safe and effective for managing pelvic kidney stones. Challenging renal anatomy stone size and density are not obstacles to the robotic approach unlike other fragmentation methods Full article
(This article belongs to the Special Issue Clinical Advances in Urinary Surgery)
Show Figures

Figure 1

12 pages, 627 KiB  
Article
Propensity Score Matching Analysis of Differential Outcomes in Holmium Laser Enucleation of the Prostate vs. Robotic-Assisted Simple Prostatectomy
by Narmina Khanmammadova, James F. Jiang, Ralph Kevin Medina Gomez, Ashley Gao, Timothy Young Chu, Mohammed Shahait, Kristene Myklak, David I. Lee and Akhil K. Das
J. Clin. Med. 2024, 13(17), 5135; https://doi.org/10.3390/jcm13175135 - 29 Aug 2024
Viewed by 1238
Abstract
Background & Objectives: Patients with bladder outlet obstruction (BOO) due to massive prostate enlargement have several surgical treatment options, such as robot-assisted simple prostatectomy (RASP) and holmium laser enucleation of the prostate (HoLEP). Postoperative outcomes may differ between those undergoing RASP and HoLEP. RASP has [...] Read more.
Background & Objectives: Patients with bladder outlet obstruction (BOO) due to massive prostate enlargement have several surgical treatment options, such as robot-assisted simple prostatectomy (RASP) and holmium laser enucleation of the prostate (HoLEP). Postoperative outcomes may differ between those undergoing RASP and HoLEP. RASP has been associated with a lower incidence of transient stress urinary incontinence (SUI), while HoLEP allows for shorter catheterization times. Here, we report on our experience with both surgical modalities. Methods: Data were collected from prospectively maintained databases for 37 RASP patients and 181 HoLEP patients treated from July 2021 to November 2023. To control for selection bias, propensity score matching (PSM) was utilized based on age and prostate size. We compared patients’ preoperative, perioperative, and postoperative outcomes both before and after applying PSM. Results: Before the PSM, the median prostate size was significantly lower in the HoLEP group (p < 0.001). The HoLEP group also had significantly shorter operative times (p ≤ 0.001) and lower weights of resected adenoma (p ≤ 0.001). After the PSM of 31 RASP and 31 HoLEP patients, all baseline patient characteristics were comparable. No significant differences were observed in operation time (p = 0.140) or in the weight of resected adenoma (p = 0.394) between the modalities. The median (IQR) length of catheterization was significantly shorter in the HoLEP group (1 [1–4] days) compared to the RASP group (7 [7–8] days), in both pre- and post-matching analyses (p ≤ 0.001 for both), reflecting the standard of practice. In contrast, in both pre- and post-PSM analyses, the average hospital stay was significantly shorter in the RASP cohort, as same-day discharge is standard in our center, whereas the HoLEP cohort required overnight stays due to routine continuous bladder irrigation before discharge (p < 0.001 for all). Notably, the SUI rates and American Urological Association (AUA) symptom scores were comparable at 3 months within both matched and unmatched cohorts (pre-PSM: p = 0.668, p = 0.083; post-PSM: p = 1, p = 0.152, respectively). Conclusions: Our comparative analysis indicates that both RASP and HoLEP yield similar outcomes, including SUI rates, at 3 months. While HoLEP provided shorter durations of postoperative catheterization, RASP offered shorter hospital stays. Full article
(This article belongs to the Special Issue Clinical Advances in Urinary Surgery)
Show Figures

Figure 1

Back to TopTop